These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 38938014)

  • 1. Correction to "Random control selection for conducting high-throughput adverse drug events screening using large-scale longitudinal health data".
    CPT Pharmacometrics Syst Pharmacol; 2024 Jul; 13(7):1280. PubMed ID: 38938014
    [No Abstract]   [Full Text] [Related]  

  • 2. Random control selection for conducting high-throughput adverse drug events screening using large-scale longitudinal health data.
    Chiang CW; Zhang P; Donneyong M; Chen Y; Su Y; Li L
    CPT Pharmacometrics Syst Pharmacol; 2021 Sep; 10(9):1032-1042. PubMed ID: 34313404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive and unbiased multiparameter high-throughput screening by compaRe finds effective and subtle drug responses in AML models.
    Chalabi Hajkarim M; Karjalainen E; Osipovitch M; Dimopoulos K; Gordon SL; Ambri F; Rasmussen KD; Grønbæk K; Helin K; Wennerberg K; Won KJ
    Elife; 2022 Feb; 11():. PubMed ID: 35166670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Automatic Quality Control Pipeline for High-Throughput Screening Hit Identification.
    Zhai Y; Chen K; Zhong Y; Zhou B; Ainscow E; Wu YT; Zhou Y
    J Biomol Screen; 2016 Sep; 21(8):832-41. PubMed ID: 27313114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NiftyPET: a High-throughput Software Platform for High Quantitative Accuracy and Precision PET Imaging and Analysis.
    Markiewicz PJ; Ehrhardt MJ; Erlandsson K; Noonan PJ; Barnes A; Schott JM; Atkinson D; Arridge SR; Hutton BF; Ourselin S
    Neuroinformatics; 2018 Jan; 16(1):95-115. PubMed ID: 29280050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Large-scale tracking and classification for automatic analysis of cell migration and proliferation, and experimental optimization of high-throughput screens of neuroblastoma cells.
    Harder N; Batra R; Diessl N; Gogolin S; Eils R; Westermann F; König R; Rohr K
    Cytometry A; 2015 Jun; 87(6):524-40. PubMed ID: 25630981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Challenges and Opportunities in Enabling High-Throughput, Miniaturized High Content Screening.
    Nickischer D; Elkin L; Cloutier N; O'Connell J; Banks M; Weston A
    Methods Mol Biol; 2018; 1683():165-191. PubMed ID: 29082493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).
    Storebø OJ; Ramstad E; Krogh HB; Nilausen TD; Skoog M; Holmskov M; Rosendal S; Groth C; Magnusson FL; Moreira-Maia CR; Gillies D; Buch Rasmussen K; Gauci D; Zwi M; Kirubakaran R; Forsbøl B; Simonsen E; Gluud C
    Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD009885. PubMed ID: 26599576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. poolHiTS: a shifted transversal design based pooling strategy for high-throughput drug screening.
    Kainkaryam RM; Woolf PJ
    BMC Bioinformatics; 2008 May; 9():256. PubMed ID: 18513431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Data-Driven Derivation of an "Informer Compound Set" for Improved Selection of Active Compounds in High-Throughput Screening.
    Paricharak S; IJzerman AP; Jenkins JL; Bender A; Nigsch F
    J Chem Inf Model; 2016 Sep; 56(9):1622-30. PubMed ID: 27487177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detecting and removing multiplicative spatial bias in high-throughput screening technologies.
    Caraus I; Mazoure B; Nadon R; Makarenkov V
    Bioinformatics; 2017 Oct; 33(20):3258-3267. PubMed ID: 28633418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of adverse events in non-randomised studies.
    Storebø OJ; Pedersen N; Ramstad E; Kielsholm ML; Nielsen SS; Krogh HB; Moreira-Maia CR; Magnusson FL; Holmskov M; Gerner T; Skoog M; Rosendal S; Groth C; Gillies D; Buch Rasmussen K; Gauci D; Zwi M; Kirubakaran R; Håkonsen SJ; Aagaard L; Simonsen E; Gluud C
    Cochrane Database Syst Rev; 2018 May; 5(5):CD012069. PubMed ID: 29744873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An efficient method for the detection and elimination of systematic error in high-throughput screening.
    Makarenkov V; Zentilli P; Kevorkov D; Gagarin A; Malo N; Nadon R
    Bioinformatics; 2007 Jul; 23(13):1648-57. PubMed ID: 17463024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pooled CRISPR Screens in Drosophila Cells.
    Viswanatha R; Brathwaite R; Hu Y; Li Z; Rodiger J; Merckaert P; Chung V; Mohr SE; Perrimon N
    Curr Protoc Mol Biol; 2019 Dec; 129(1):e111. PubMed ID: 31763777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Linezolid for drug-resistant pulmonary tuberculosis.
    Singh B; Cocker D; Ryan H; Sloan DJ
    Cochrane Database Syst Rev; 2019 Mar; 3(3):CD012836. PubMed ID: 30893466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive modeling of structured electronic health records for adverse drug event detection.
    Zhao J; Henriksson A; Asker L; Boström H
    BMC Med Inform Decis Mak; 2015; 15 Suppl 4(Suppl 4):S1. PubMed ID: 26606038
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.